Cargando…
Low-dose Ketamine Does Not Improve Migraine in the Emergency Department: A Randomized Placebo-controlled Trial
INTRODUCTION: Patients frequently present to the emergency department (ED) with migraine headaches. Although low-dose ketamine demonstrates analgesic efficacy for acute pain complaints in the ED, headaches have historically been excluded from these trials. This study evaluates the efficacy and safet...
Autores principales: | Etchison, Ashley R., Bos, Lia, Ray, Meredith, McAllister, Kelly B., Mohammed, Moiz, Park, Barrett, Phan, Allen Vu, Heitz, Corey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Department of Emergency Medicine, University of California, Irvine School of Medicine
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6225951/ https://www.ncbi.nlm.nih.gov/pubmed/30429927 http://dx.doi.org/10.5811/westjem.2018.8.37875 |
Ejemplares similares
-
Reduction in migraine-associated burden after eptinezumab treatment in patients with chronic migraine
por: McAllister, Peter, et al.
Publicado: (2022) -
Efficacy of ketamine in the treatment of migraines and other unspecified primary headache disorders compared to placebo and other interventions: a systematic review
por: Chah, Neysan, et al.
Publicado: (2021) -
The temporal trend of placebo response in migraine prevention from 1990 to 2021: a systematic literature review and meta-analysis with regression
por: Tepper, Stewart J., et al.
Publicado: (2023) -
A Randomized, Double-Blind, Placebo-Controlled Study of Breath Powered Nasal Delivery of Sumatriptan Powder (AVP-825) in the Treatment of Acute Migraine (The TARGET Study)
por: Cady, Roger K, et al.
Publicado: (2015) -
Intravenous ketamine for subacute treatment of refractory chronic migraine: a case series
por: Lauritsen, Clinton, et al.
Publicado: (2016)